[PLX] QoQ Quarter Result on 30-Sep-2024 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
14-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 246.89%
YoY- 274.73%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 17,959 13,474 3,748 10,486 10,345 35,075 9,588 51.77%
PBT 3,843 -2,272 -4,733 -6,426 -1,719 19,647 -2,936 -
Tax 607 -69 -138 -382 133 308 195 112.75%
NP 3,236 -2,203 -4,595 -6,044 -1,852 19,339 -3,131 -
Tax Rate -15.79% - - - - -1.57% - -
Total Cost 14,723 15,677 8,343 16,530 12,197 15,736 12,719 10.21%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 18.02 -16.35 -122.60 -57.64 -17.90 55.14 -32.66 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS 0.04 -0.03 -0.06 -0.08 -0.03 0.29 -0.05 -
EPS Diluted 0.04 -0.03 -0.06 -0.08 -0.02 0.21 -0.05 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.